NCT00712465View on ClinicalTrials.gov

An Interaction Study With Digoxin and AZD1305

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Atrial Fibrillation
Interventions
DRUG

AZD1305

Extended Release tablet, repeated administration

DRUG

Digoxin

Tablet, repeated administration

Trial Locations (1)

Unknown

Research Site, Gothenburg

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY